Futura Medical Hits Milestone with First Profit, Prepares for US Ero...

Futura Medical PLC (LSE:FUM) CEO James Barder recently discussed the company's latest financial performance and future outlook with Proactive's Stephe...

hVIVO CEO Highlights Record H1 Revenue and Strategic Expansion

hVIVO PLC,(LSE:HVO),CEO Yamin (Mo) Khan recently discussed the company’s notable achievements in the first half of 2024 with Proactive's Stephen Gunni...

ImmuPharma reports interim progress on lead asset

ImmuPharma PLC,(LSE:IMM),has reported progress in developing treatments for autoimmune diseases, with a focus on Systemic Lupus Erythematosus (SLE) an...

Hutchmed to Present New and Updated Clinical Trial Data

Hutchmed China,(LSE:HCM),has announced that it will present new and updated clinical trial data at two major oncology conferences: the 2024 World Conf...

RUA Life Sciences Acquires French Implantable Devices Company

RUA Life Sciences,(LSE:RUA),has completed the acquisition of implantable devices manufacturer Analytic Biosurgical Solutions for €80,000. The purchase...

Oncimmune Shares Surge Following Contract Wins

Shares in Oncimmune, a company specializing in autoantibody profiling, saw a significant rise on Monday after the firm reported strong commercial prog...

Hemogenyx Pharmaceuticals Reaches Critical Milestone

A prominent player of,Healthcare Sector,Hemogenyx Pharmaceuticals PLC has announced the successful development of a clinical-grade assay designed to m...

GSK Reports Positive Results from COPD Trial

On Friday, GSK,(LSE:GSK),reported positive results from its phase three ‘MATINEE’ clinical trial, which assessed the efficacy of ‘Nucala’ (mepolizumab...

GSK Reports Positive COPD Trial Results

Successful MATINEE Trial Results,GSK PLC,(LSE:GSK),has announced encouraging results from the Phase III clinical trial named MATINEE, which assessed t...

Indivior’s CUD Study Falls Short of Primary and Secondary Endpoints

On Wednesday, Indivior,(LSE:INDV),reported that the Phase 2B clinical trial conducted by Aelis Farma on the drug AEF0117 for treating cannabis use dis...

Aptamer Renews Contract with Unilever

On Tuesday, Aptamer,(LSE:APTA),, a company specializing in custom antibody alternatives, announced the extension of its contract with Unilever to adva...

Oxford Nanopore Shows Steady First Half Amid Market Challenges

On Tuesday, Oxford Nanopore Technologies,(LSE:ONT),reported a steady performance for the first half of the year, despite facing challenging market con...

Aptamer Group Gains Boost from Unilever Collaboration Extension

Shares of Aptamer Group PLC,(LSE:APTA),saw a 4% increase following the announcement of an extended contract with consumer giant Unilever PLC. The part...

Uniphar reports first-half growth in all its divisions

On Tuesday, Uniphar,(LSE:UPR),, an international diversified healthcare service provider, reported robust first-half financial results, showcasing sig...

Berenberg upgrades Hikma Pharmaceuticals

On Tuesday, Berenberg upgraded Hikma Pharmaceuticals,(LSE:HIK),, raising the price target from 2,100p to 2,400p, citing significant progress within th...

Futura Medical Soars as Eroxon Launches in US Stores and Online in O...

Futura Medical PLC,(LSE:FUM),has provided additional details regarding the US launch of its innovative erectile dysfunction gel, Eroxon, in collaborat...

Roquefort Therapeutics Secures European Patent for MK Cell Therapy

Roquefort Therapeutics PLC, a company operating within the,Healthcare sector,, has achieved a significant milestone with the European Patent Office gr...

Oncimmune Wins New Contract with Top Ten Global Pharma Company

Oncimmune,(LSE:ONC),, a biotechnology firm, revealed on Monday that it has secured a significant new contract with a leading global pharmaceutical com...

GSK's RSV Vaccine Receives Expanded Approval in Europe

On Thursday, GSK,(LSE:GSK),announced that the European Commission has approved its respiratory syncytial virus (RSV) vaccine, Arexvy, for use in adult...

Totally Secures Multiple New Contracts and Extensions

On Thursday, Totally,(LSE:TLY),, a healthcare services company, announced several new contracts and extensions in England and Ireland, with a total va...